Results 191 to 200 of about 11,680 (228)

Low-Dose Acitretin for Secondary Prevention of Keratinocyte Carcinomas in Solid-Organ Transplant Recipients

Dermatology, 2021
Background: Keratinocyte carcinomas, particularly squamous cell carcinoma (SCC), occur more frequently and aggressively in solid-organ transplant recipients (SOTRs) than in the general population.
Efrat Solomon-Cohen, S. Reiss-Huss, E. Hodak, B. Davidovici   +3 more
semanticscholar   +1 more source

Retrospective study of the efficacy of narrowband UVB and acitretin

Journal of Dermatological Treatment, 2003
BACKGROUND: In this retrospective analysis the effect of narrowband ultraviolet B treatment in combination with acitretin is reviewed in 40 patients with plaque psoriasis.
P I Spuls
exaly   +1 more source

Enhancing topical acitretin delivery: formulation and evaluation of solid lipid nanoparticles for efficient skin therapy through in vitro and ex vivo testing

Journal of Dispersion Science and Technology
Oral vitamin-A derivative acitretin treats severe psoriasis. Oral capsules are commercially available preparation and have severe systemic adverse effects.
P. Panmand, P. Mahaparale, Mohd Sayeed Shaikh, S. Mahaparale   +3 more
semanticscholar   +1 more source

Repurposing Acitretin as an Antipseudomonal Agent Targeting the Pseudomonas aeruginosa Iron-Regulated Heme Oxygenase.

Biochemistry, 2021
Iron is an essential micronutrient for the survival and virulence of the bacterial pathogen Pseudomonas aeruginosa. To overcome iron withholding and successfully colonize a host, P.
Elizabeth Robinson, A. Wilks, F. Xue
semanticscholar   +1 more source

Inclusion of Acitretin into Cyclodextrins: Phase Solubility, Photostability, and Physicochemical Characterization

Journal of Pharmaceutical Sciences, 2003
Acitretin, a retinoid for the treatment of severe psoriasis, exhibits extremely low aqueous solubility and high photosensitivity. This study investigated the effects of the complexation of acitretin with the respective hydroxypropyl-beta-cyclodextrin ...
Sui Yung Chan, Paul Ho, Hai-Shu Lin
exaly   +2 more sources

Managing chromoblastomycosis with acitretin plus imiquimod: A case report on the improvement of cutaneous lesions and reduction of the treatment time

Journal of dermatology (Print), 2021
Chromoblastomycosis (CBM) is an infectious disease caused by fungi that is prevalent in tropical and subtropical countries. Besides few therapeutic options, the classical treatment of CBM needs to be administrated for a long period of time, and ...
W. Belda, Ana T. S. Casolato, J. Luppi, L. Passero   +3 more
semanticscholar   +1 more source

Is the first‐line systemic chemoprevention of nonmelanoma skin cancer nicotinamide or acitretin?

International Journal of Dermatology, 2021
In the United States, the annual cost of treating nonmelanoma skin cancer (NMSC) is approximately $4.8 billion, and the incidence of NMSC is increasing worldwide. Sunscreen is the most frequently used prophylactic agent against NMSC.
K. Hoegler, A. Khachemoune
semanticscholar   +1 more source

Development, characterization and evaluation of nanocarrier based formulations of antipsoriatic drug “acitretin” for skin targeting

Journal of Drug Delivery Science and Technology, 2020
Acitretin, a 2nd generation retinoid, is a drug of choice for the treatment of severe psoriasis. Presently, only capsule formulation for oral administration is commercially available and associated with limitations of severe systemic side effects. In the
N. Kaur, M. Kaur, M. Mahajan, S. Jain
semanticscholar   +1 more source

Repigmentation and curling of hair after acitretin therapy

Australasian Journal of Dermatology, 2009
Drug-induced hair colour and texture changes have been reported rarely. We describe a 70-year-old woman with psoriasis who noticed darkening of her previously white hair, which also gained a curly appearance after 6 months of acitretin treatment.
SEÇKİN GENÇOSMANOĞLU, DİLEK
exaly   +2 more sources

Acitretin

Reactions Weekly, 2017
  +7 more sources